Latest

Pharm Exec's Emerging Pharma Leaders 2017

Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.

The Future of Real-World Studies

What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?

How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’

Today’s model requires a fourth partner—the systems integrator, writes Adam Nelson.

TESARO: Setting New Benchmarks in Patient-Centricity

TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.

PharmExec Videos

New & Noteworthy

Glimmers of Hope for Innovation Support in Europe

European Commission talks drug industry investment, health issues during State of the Union.

NASH: Pointers for Pharma from the Patient Perspective

With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.

Strategies for Successful Market Access in the Untapped NASH Market

Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.

The Rising Tide of Next Generation Cancer Treatments

Jackie Ilacqua & Valerie Wriede trace the evolution of cancer treatment and drill down into the latest developments currently redefining the landscape, together with those on the horizon.

Pharm Exec's 16th Annual Industry Audit

Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.

The Supply Chain: What Price Patient Centricity?

Can the pharma industry truly achieve a patient-centric supply chain? How some clinical trial logistics companies are racing ahead in making the patient a key link in the chain.

Sales & Marketing

Are We Slaves to Predictability?

The status quo pharma marketing model is still relied upon by the big brands, not because the results are amazing, but because they are predictable. It's time to challenge convention, says James Talerico.

How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity

Healthcare companies are overwhelming physicians and hospitals with brand messaging overlap. Let’s use data science to fix that, says Kevin Troyanos.

Survival/Success in the Age of Too Much Information

For marketers, getting messages out in the age of polarization and "TMI" requires common sense and courage, says Al Topin.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

Are We Slaves to Predictability?

The status quo pharma marketing model is still relied upon by the big brands, not because the results are amazing, but because they are predictable. It's time to challenge convention, says James Talerico.

Clinical Trials Confusing—Even to Doctors

Most physicians and many specialists have limited understanding of clinical trial data and research findings presented in prescription drug promotional materials for professional audiences.

Rebooting Life Sciences with Digital

Bhaskar Sambasivan offers a prescription for thriving in the new digital economy.

Can Streamlined R&D Reduce Drug Prices?

FDA seeks to de-risk research and promote competition to achieve savings for patients and plans.

Compliance Top of Mind

There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.
 

Read More.

Interviews

Pharm Exec's Emerging Pharma Leaders 2017

Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.

TESARO: Setting New Benchmarks in Patient-Centricity

TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.

Leading With Patients in Mind: Cynthia Schwalm

Cynthia Schwalm, EVP and president of North American commercial operations for Ipsen, talks to Pharm Exec about the importance of stepping outside of the C-suite and into the world of the patient.

Health Policy Problem Solver: Fumie Griego

IFPMA's new Assistant Director General speaks about her mission to use the organization’s international reach to find real and practical solutions to the most pressing global healthcare challenges.

Regulatory

Can Streamlined R&D Reduce Drug Prices?

FDA seeks to de-risk research and promote competition to achieve savings for patients and plans.

FDA Considers More Targeted Risk Information in DTC Ads

FDA is evaluating whether limiting warnings in TV commercials to the most serious adverse effects might be more informative for consumers than the current laundry lists of potential side effects.

FDA, Manufacturers Strive to Prevent Drug Shortages from Hurricane Maria

The extensive volume of pharmaceutical manufacturing in Puerto Rico is driving FDA efforts to assess facility damage and logistical problems to ensure continued supply of critical medicines. Jill Wechsler reports.

From the Editor

Inspiring People, Inspiring Teams

As we again highlight a roster of emerging leaders in pharma, I wanted to recognize Pharm Exec's own unique team behind the scenes.

You Are Pharma

A big thank you to you, our readers, for lending your voice to Pharm Exec's editorial mission—giving you the information you need and want. Click ahead for a look at some of the future topics we'll be tackling.

lorem ipsum